Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CRL
SMMT
Add up to 3 more stocks
CRL
Charles River Laboratories International, Inc.
-1.87%
$304.96-5.81Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$14.69B
52W Range
$146.20 - $333.30
SMMT
Summit Therapeutics Inc.
+0.23%
$17.31+0.04Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$13.81B
52W Range
$12.07 - $29.23
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | 26.87 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 5.17 | 21.92 |
| P/S Ratio | 3.67 | N/A |
| P/FCF Ratio | 39.64 | N/A |
| EV/EBITDA | 22.14 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 32.2% | 0.0% |
| Operating Margin | 12.3% | 0.0% |
| Net Margin | -6.0% | 0.0% |
| ROE | -8.4% | -135.9% |
| ROA | -3.2% | -113.8% |
| ROIC | 7.7% | -134.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.35 | 6.96 |
| Quick Ratio | 1.04 | 6.96 |
| Debt/Equity | 1.07 | 0.03 |
| Interest Coverage | 4.74 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.